Data / Form D filings / AllergEase Inc
AllergEase Inc: Form D filings
AllergEase Inc, a pharmaceuticals company in Danville, VA, filed 2 Form D notices with the SEC between 2013 and 2014. The latest, on April 3, 2014, reports $1.1 million sold of a $1.5 million offering to 42 investors.
Find out what AllergEase Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 541 BRIDGE STREET, SUITE 2, Danville, VA, 24541
- Phone
- (703) 926-7215
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1569902
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2014 | Amendment | $1,500,000 | $1,080,959 | $419,041 | 42 | Feb 4, 2013 | sec.gov |
| Feb 19, 2013 | New notice | $1,500,000 | $407,500 | $1,092,500 | 7 | Feb 4, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dan Nelson Engel | Director | |
| Xandra Nelson Laskowski | Director | |
| Luke Nelson Fry | Director | |
| Omar Javery | Executive Officer, Director | |
| Nancy Lai Sum Wong | Executive Officer, Director | |
| Zeeshan Kaba | Executive Officer, Director | |
| Sam Nelson Yousefzadeh | Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Mar 31, 2014 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AllergEase Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.